# Corning Incorporated  Share Price Target ‘$35.64’, now 1.2% Upside Potential

- Link: https://www.directorstalkinterviews.com/corning-incorporated-share-price-target-35.64-now-1.2-upside-potential/4121157881
- Published: 2024-05-20T14:24:07+01:00
- Author: Charlotte Edwards

**Corning Incorporated** which can be found using ticker (GLW) have now 11 confirmed
analysts covering the stock with the consensus suggesting a rating of ‘buy’. The
target price High/Low ranges between $40.00 and $29.00 with the average share target
price sitting at $35.64. (at the time of writing). Given that the stocks previous
close was at $35.22 this indicates there is a potential upside of 1.2%. The day 
50 moving average is $32.72 and the 200 day MA is $30.99. The company has a market
cap of 30.28B. The current stock price for Microsoft Corporation is currently $35.35
USD

 The potential market cap would be $30,642,588,133 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 49.1, revenue per share of $14.57
and a 2.85% return on assets.

Corning Incorporated is a materials science technology and innovation company. The
Company operates through five segments: Optical Communications, Display Technologies,
Specialty Materials, Environmental Technologies and Life Sciences. The Optical Communications
segment manufactures carrier network and enterprise network components for the telecommunications
industry. The Display Technologies segment manufactures glass substrates for flat
panel liquid crystal displays and other high-performance display panels. Its Specialty
Materials segment is engaged in manufacturing products that provide material formulations
for glass, glass ceramics and fluoride crystals to meet demand for customer needs.
Its Environmental Technologies segment manufactures ceramic substrates and filters
for emission control systems. Its Life Sciences segment manufactures glass and plastic
labware, equipment, media, serum and reagents enabling workflow solutions for drug
discovery and bioproduction.

Share on:
